Cheddar News
146

Genexa CEO on Disrupting Big Pharma With 'Clean' OTC Medicine

Genexa has deemed itself "the first clean medicine company" and looks to disrupt big pharma by providing over-the-counter medicines that are free of what it calls unnecessary or unhealthy ingredients. On the heels of a $60 million Series A fundraise, co-founder and CEO David Johnson joined Cheddar's Closing Bell to talk about how the company differentiates itself from its pharmaceutical competitors.

Science

Latest News

Business & Tech

Culture